Teva Pharma Gets Approval to Market Generic Nasal Spray for Opioid Overdoses - WSJ
TEVA News Today | Why did Teva Pharmaceutical Industries stock go up today?
Teva sells Overland Park business segment - Kansas City Business Journal
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Outsourcing active medicine ingredients leaves EU patients at risk
Teva ends enrollment in late-stage Austedo cerebral palsy trial (NYSE:TEVA) | Seeking Alpha
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceutical Stock Could Double | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Pharmaceutical Industries Ltd. | Global Philadelphia Association
Teva Pharma News, Teva Pharma Quote, TEVA Quote - StreetInsider.com
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva looks to amp up research collaborations, CEO says
teva News and latest stories | The Jerusalem Post
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva, one of the biggest generic makers, joins the the brand-name club
Teva CEO Schultz likely won't renew employment contract: reports
